With both Mithra and Mayne Pharma
down 30% and 50% respectively since
April when Nextellis was given FDA go
ahead in USA.
There has been not one Institution take
a position of consequence .
So much for Corbett and his Company
changing forecasts.
I really hope this remains the Legacy of
his Professional career.
With both Mithra and Mayne Pharma down 30% and 50% respectively...
-
- There are more pages in this discussion • 212 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.39 |
Change
-0.040(0.90%) |
Mkt cap ! $373.4M | |||
| Open | High | Low | Value | Volume |
| $4.44 | $4.48 | $4.22 | $618.1K | 142.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 693 | $4.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.40 | 2133 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| MYX (ASX) Chart |